Skip to content
Sunday, August 14, 2022
Latest:
  • Forced to flee: Barriers to care in local refugee populations
  • Throwback Thursday: The first Image of the Month
  • When should you start your child in swimming lessons?
  • 6 tips to kickstart your day
  • Genome-wide study reveals new susceptibility genetic variants for lung cancer

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

TapImmune

From The Labs 

From the labs to commercialization: Companies merge to implement Baylor College of Medicine-developed therapies for cancer

August 16, 2018August 16, 2018cancer therapy, commercialization, Marker Therapeutics, Research, T cells, TapImmune, tumor cells

Despite major advances in cancer therapy, conventional cancer treatments continue to be associated with devastating side effects for patients and are not always curative. In

Read more

From the Labs Video of the Month

From The Labs Image of the Month From the Labs: A beating developing mouse heart.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951